# The Wild West of Medicinal Cannabis Prescriptions – i Newspaper > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medicinal-cannabis-prescribing-standards-patient-safety/ > **Published:** 2026-03-29T21:02:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:35:11-04:00 > **Clinical Summary:** Explore medicinal cannabis prescribing standards and their role in improving patient safety and therapeutic outcomes in clinical practice. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic RegulationPrescribing StandardsPatient SafetyClinical Protocols[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) Why This Matters Regulatory inconsistencies in [cannabis prescribing](https://cedclinic.com/addressing-cannabis-education-gap-clinical-care/) create patient safety risks and undermine therapeutic outcomes. When prescribing practices lack standardization, patients receive variable quality care and clinicians operate without clear evidence-based protocols. Clinical Summary The UK’s medicinal cannabis landscape demonstrates the challenges of implementing controlled therapeutic cannabis programs without robust clinical frameworks. Variable prescribing practices, inconsistent product standardization, and limited clinical guidance create a fragmented treatment environment. This mirrors early implementation challenges seen in other jurisdictions where regulatory structures preceded comprehensive clinical protocols. Dr. Caplan’s Take “Unregulated prescribing isn’t just poor medicine—it’s actively harmful to the field’s credibility. We need standardized protocols, consistent product quality, and outcome tracking before we can claim therapeutic legitimacy.” Clinical Perspective 🧠 Clinicians should prioritize evidence-based dosing protocols and verified product analysis when available. Patients benefit most from structured treatment approaches with clear outcome metrics rather than ad-hoc prescribing. This regulatory inconsistency underscores the importance of working within established medical frameworks. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20Wild%20West%20of%20medicinal%20cannabis%20prescriptions%20-%20i%20Newspaper%20%40drcaplan&url=https%3A//inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20Wild%20West%20of%20medicinal%20cannabis%20prescriptions%20-%20i%20Newspaper%20--%20via%20%40drcaplan.bsky.social%20https%3A//inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330](https://inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What key areas does this cannabis regulation update cover?](#What_key_areas_does_this_cannabis_regulation_update_cover) - [Why is this considered emerging information?](#Why_is_this_considered_emerging_information) - [How does this relate to prescribing standards?](#How_does_this_relate_to_prescribing_standards) - [What should clinicians know about the patient safety implications?](#What_should_clinicians_know_about_the_patient_safety_implications) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. #### What key areas does this cannabis regulation update cover? The update focuses on four main areas: regulation, prescribing standards, patient safety, and clinical protocols. These represent core aspects of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) practice that impact both providers and patients. #### Why is this considered emerging information? The article is marked as “New” and categorized under emerging findings or policy developments. This suggests recent changes or discoveries in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) that require ongoing attention from the clinical community. #### How does this relate to prescribing standards? The prescribing standards component likely addresses updated guidelines for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) recommendations. This could include dosing protocols, patient selection criteria, or documentation requirements for healthcare providers. #### What should clinicians know about the patient safety implications? Patient safety is highlighted as a key focus area, suggesting the update includes important safety considerations for medical [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). Clinicians should pay attention to new safety protocols, contraindications, or monitoring requirements outlined in these developments. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “The Wild West of medicinal cannabis prescriptions – i Newspaper”, “url”: “https://inews.co.uk/news/health/wild-west-medicinal-cannabis-prescriptions-4323330”, “datePublished”: “2026-03-29T22:43:44Z”, “about”: “wild west medicinal cannabis prescriptions i”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Bill to protect Nebraska health professionals who recommend medical cannabis advances](https://cedclinic.com/medical-cannabis-professional-liability-nebraska/) Learn about legislative efforts to safeguard healthcare providers recommending medical cannabis, enhancing clinical practice protections. [Read More](https://cedclinic.com/medical-cannabis-professional-liability-nebraska/) [Will medicinal cannabis help my mental health? Here are the evidence and the risks](https://cedclinic.com/medicinal-cannabis-demand-mental-health-soars-evidence-risks/) Explore the evidence and risks surrounding medicinal [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for mental health conditions to inform safe clinical decisions. [Discover Insights](https://cedclinic.com/medicinal-cannabis-demand-mental-health-soars-evidence-risks/) [Health professionals say new rules gives government too much disciplinary power](https://cedclinic.com/regulatory-uncertainty-cannabis-prescribing/) Understand concerns from health professionals about regulatory changes affecting medical [cannabis prescribing](https://cedclinic.com/addressing-cannabis-education-gap-clinical-care/) and clinical autonomy. [Learn More](https://cedclinic.com/regulatory-uncertainty-cannabis-prescribing/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).